PT  - JOURNAL ARTICLE
AU  - Ranoa, Diana Rose E.
AU  - Holland, Robin L.
AU  - Alnaji, Fadi G.
AU  - Green, Kelsie J.
AU  - Wang, Leyi
AU  - Fredrickson, Richard L.
AU  - Wang, Tong
AU  - Wong, George N.
AU  - Uelmen, Johnny
AU  - Maslov, Sergei
AU  - Elbanna, Ahmed
AU  - Weiner, Zachary J.
AU  - Tkachenko, Alexei V.
AU  - Zhang, Hantao
AU  - Liu, Zhiru
AU  - Patel, Sanjay J.
AU  - Paul, John M.
AU  - Vance, Nickolas P.
AU  - Gulick, Joseph G.
AU  - Satheesan, Sandeep Puthanveetil
AU  - Galvan, Isaac J.
AU  - Miller, Andrew
AU  - Grohens, Joseph
AU  - Nelson, Todd J.
AU  - Stevens, Mary P.
AU  - Hennessy, P. Mark
AU  - Parker, Robert C.
AU  - Santos, Edward
AU  - Brackett, Charles
AU  - Steinman, Julie D.
AU  - Fenner, Melvin R.
AU  - Dohrer, Kirstin
AU  - Wagenecht, Kraig
AU  - DeLorenzo, Michael
AU  - Wilhelm-Barr, Laura
AU  - Brauer, Brian R.
AU  - Best-Popescu, Catherine
AU  - Durack, Gary
AU  - Wetter, Nathan
AU  - Kranz, David M.
AU  - Breitbarth, Jessica
AU  - Simpson, Charlie
AU  - Pryde, Julie A.
AU  - Kaler, Robin N.
AU  - Harris, Chris
AU  - Vance, Allison C.
AU  - Silotto, Jodi L.
AU  - Johnson, Mark
AU  - Valera, Enrique
AU  - Anton, Patricia K.
AU  - Mwilambwe, Lowa
AU  - Bryan, Stephen P.
AU  - Stone, Deborah S.
AU  - Young, Danita B.
AU  - Ward, Wanda E.
AU  - Lantz, John
AU  - Vozenilek, John A.
AU  - Bashir, Rashid
AU  - Moore, Jeffrey S.
AU  - Garg, Mayank
AU  - Cooper, Julian C.
AU  - Snyder, Gillian
AU  - Lore, Michelle H.
AU  - Yocum, Dustin L.
AU  - Cohen, Neal J.
AU  - Novakofski, Jan E.
AU  - Loots, Melanie J.
AU  - Ballard, Randy L.
AU  - Band, Mark
AU  - Banks, Kayla M.
AU  - Barnes, Joseph D.
AU  - Bentea, Iuliana
AU  - Black, Jessica
AU  - Busch, Jeremy
AU  - Christensen, Hannah
AU  - Conte, Abigail
AU  - Conte, Madison
AU  - Curry, Michael
AU  - Eardley, Jennifer
AU  - Edwards, April
AU  - Eggett, Therese
AU  - Fleurimont, Judes
AU  - Foster, Delaney
AU  - Fouke, Bruce W.
AU  - Gallagher, Nicholas
AU  - Gastala, Nicole
AU  - Genung, Scott A.
AU  - Glueck, Declan
AU  - Gray, Brittani
AU  - Greta, Andrew
AU  - Healy, Robert M.
AU  - Hetrick, Ashley
AU  - Holterman, Arianna A
AU  - Ismail, Nahed
AU  - Jasenof, Ian
AU  - Kelly, Patrick
AU  - Kielbasa, Aaron
AU  - Kiesel, Teresa
AU  - Kindle, Lorenzo M.
AU  - Lipking, Rhonda L.
AU  - Manabe, Yukari C.
AU  - Mayes, Jade
AU  - McGuffin, Reubin
AU  - McHenry, Kenton G.
AU  - Mirza, Agha
AU  - Moseley, Jada
AU  - Mostafa, Heba H.
AU  - Mumford, Melody
AU  - Munoz, Kathleen
AU  - Murray, Arika D.
AU  - Nolan, Moira
AU  - Parikh, Nil A.
AU  - Pekosz, Andrew
AU  - Pflugmacher, Janna
AU  - Phillips, Janise M.
AU  - Pitts, Collin
AU  - Potter, Mark C.
AU  - Quisenberry, James
AU  - Rear, Janelle
AU  - Robinson, Matthew L.
AU  - Rosillo, Edith
AU  - Rye, Leslie N.
AU  - Sherwood, MaryEllen
AU  - Simon, Anna
AU  - Singson, Jamie M.
AU  - Skadden, Carly
AU  - Skelton, Tina H.
AU  - Smith, Charlie
AU  - Stech, Mary
AU  - Thomas, Ryan
AU  - Tomaszewski, Matthew A.
AU  - Tyburski, Erika A.
AU  - Vanwingerden, Scott
AU  - Vlach, Evette
AU  - Watkins, Ronald S.
AU  - Watson, Karriem
AU  - White, Karen C.
AU  - Killeen, Timothy L.
AU  - Jones, Robert J.
AU  - Cangellaris, Andreas C.
AU  - Martinis, Susan A.
AU  - Vaid, Awais
AU  - Brooke, Christopher B.
AU  - Walsh, Joseph T.
AU  - Sullivan, William C.
AU  - Smith, Rebecca L.
AU  - Goldenfeld, Nigel D.
AU  - Fan, Timothy M.
AU  - Hergenrother, Paul J.
AU  - Burke, Martin D.
TI  - Mitigation of SARS-CoV-2 Transmission at a Large Public University
AID  - 10.1101/2021.08.03.21261548
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.03.21261548
4099  - http://medrxiv.org/content/early/2021/08/05/2021.08.03.21261548.short
4100  - http://medrxiv.org/content/early/2021/08/05/2021.08.03.21261548.full
AB  - In the Fall of 2020, many universities saw extensive transmission of SARS-CoV-2 among their populations, threatening the health of students, faculty and staff, the viability of in-person instruction, and the health of surrounding communities.1, 2 Here we report that a multimodal “SHIELD: Target, Test, and Tell” program mitigated the spread of SARS-CoV-2 at a large public university, prevented community transmission, and allowed continuation of in-person classes amidst the pandemic. The program combines epidemiological modelling and surveillance (Target); fast and frequent testing using a novel and FDA Emergency Use Authorized low-cost and scalable saliva-based RT-qPCR assay for SARS-CoV-2 that bypasses RNA extraction, called covidSHIELD (Test); and digital tools that communicate test results, notify of potential exposures, and promote compliance with public health mandates (Tell). These elements were combined with masks, social distancing, and robust education efforts. In Fall 2020, we performed more than 1,000,000 covidSHIELD tests while keeping classrooms, laboratories, and many other university activities open. Generally, our case positivity rates remained less than 0.5%, we prevented transmission from our students to our faculty and staff, and data indicate that we had no spread in our classrooms or research laboratories. During this fall semester, we had zero COVID-19-related hospitalizations or deaths amongst our university community. We also prevented transmission from our university community to the surrounding Champaign County community. Our experience demonstrates that multimodal transmission mitigation programs can enable university communities to achieve such outcomes until widespread vaccination against COVID-19 is achieved, and provides a roadmap for how future pandemics can be addressed.Competing Interest StatementUniversity of Illinois at Urbana-Champaign has filed a patent application related to the saliva-based assay described herein (U.S. Patent Application No.: 63/040,612), and D.R.E.R., R.L.H., F.G.A., K.J.G., L.W., C.R.B., M.D.B., T.M.F., and P.J.H are co-inventors. S.J.P., J.M.P., W.C.S., R.J.J., and A.C.C. are associated with Rokwire, which created the Safer Illinois App. G.D. and N.W. are associated with TekMill which created some of the automation used in the VDL COVID-19 Testing Lab at UIUC.Clinical TrialWestern IRB-approved protocol number 20203538Funding StatementWe gratefully acknowledge University of Illinois at Urbana-Champaign for funding. UIUC has also received support from CIMIT through the POCTRN program. CIMIT and POCTRN are supported by the RADx Tech program and have been funded in part with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Grant No. U54EB015408. This work was supported by the University of Illinois System Office, the Office of the Vice-Chancellor for Research and Innovation, the Grainger College of Engineering, and the Department of Physics at the University of Illinois at Urbana-Champaign. Z.J.W. is supported in part by the United States Department of Energy Computational Science Graduate Fellowship, provided under Grant No. DE-FG02-97ER25308. A.E. acknowledges partial support by NSF CAREER Award No. 1753249. This work made use of the Illinois Campus Cluster, a computing resource that is operated by the Illinois Campus Cluster Program (ICCP) in conjunction with the National Center for Supercomputing Applications (NCSA) and which is supported by funds from the University of Illinois at Urbana-Champaign. This research was partially done at, and used resources of the Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No.∽DE-SC0012704. This study was also partially funded by the National Institute for Biomedical Imaging and Bioengineering grant number U54EB027690, part of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Western IRB-approved protocol number 20203538All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregate case and testing data are publicly available at https://go.illinois.edu/COVIDTestingData All other data may be requested through the COVID Research Oversight Committee at https://forms.illinois.edu/sec/1409755003 Link to the code for analysis of county-level mortality in the BigTen: https://github.com/juel15401/Big10UniversityCounties_COVID.git Code Availability Source code repository of "Safer Illinois" App - the official COVID-19 app of the University of Illinois: https://github.com/rokwire/safer-illinois-app